Format

Send to

Choose Destination
Genet Med. 2019 Jan 22. doi: 10.1038/s41436-019-0440-2. [Epub ahead of print]

Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.

Author information

1
Department of Medicine (Medical Genetics), University of Washington, Seattle, WA, USA. hartmr@uw.edu.
2
Clinical Sequencing Exploratory Research Coordinating Center, University of Washington, Seattle, WA, USA. hartmr@uw.edu.
3
Social and Behavioral Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
4
Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
5
Harvard Medical School, Boston, MA, USA.
6
Department of Medicine (Medical Genetics), University of Washington, Seattle, WA, USA.
7
Clinical Sequencing Exploratory Research Coordinating Center, University of Washington, Seattle, WA, USA.
8
Department of Pediatrics, Oncology Section, Baylor College of Medicine, Houston, TX, USA.
9
Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
10
HudsonAlpha Institute for Biotechnology, Huntsville, AL, USA.
11
Department of Pediatrics, University of Louisville, Louisville, KY, USA.
12
Division of Genomic Diagnostics, Department of Pathology and Laboratory Medicine, The Children's Hospital, Philadelphia, PA, USA.
13
Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
14
Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
15
Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
16
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
17
Department of Medical Genetics, Kaiser Permanente Northwest, Portland, OR, USA.
18
Center for Health Research, Kaiser Permanente Northwest, Portland, OR, USA.
19
Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
20
Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA.
21
Laboratory for Molecular Medicine, Partners HealthCare, Cambridge, MA, USA.
22
Broad Institute of MIT and Harvard, Cambridge, MA, USA.
23
Knight Diagnostic Laboratories, Oregon Health Science University, Portland, OR, USA.
24
VA Boston Healthcare System, Boston, MA, USA.
25
Department of Pediatrics and Seattle Children's Research Institute, University of Washington, Seattle, WA, USA.
26
Department of Pharmacy, University of Washington, Seattle, WA, USA.
27
Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
28
Partners Personalized Medicine, Boston, MA, USA.
29
Division of Genomic Medicine, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. hindorffl@mail.nih.gov.

Abstract

The originally published version of this Article contained errors in Fig. 2. The numbers below the black arrowheads were incorrect; please see incorrect Figure in associated Correction. These errors have now been corrected in the PDF and HTML versions of the Article.

PMID:
30670880
DOI:
10.1038/s41436-019-0440-2

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center